SCHEMBL900786

SCHEMBL900786

Cc1cc(Cl)cc(OC(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
LMNA P02545 3/20 0.36
MAPT P10636 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
RAB9A P51151 2/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
GAA P10253 2/20 0.36
SMN1; SMN2 Q16637 4/20 0.35
F2RL3 Q96RI0 1/20 0.34
KCNH2 Q12809 1/20 0.34
RAPGEF4 Q8WZA2 2/20 0.31
EPAS1 Q99814 1/20 0.31
ALDH1A1 P00352 1/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16960385 0.84 ALDH1A1 (0.41) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL16950695 0.84 MAPT (0.36) MEN1KMT2ALMNAMAPTNPSR1
SCHEMBL16483015 0.81 FFAR4 (0.37) LMNAGAAALDH1A1SCN4A
SCHEMBL15864862 0.79 ALDH1A1 (0.46) MEN1KMT2ALMNAMAPTNPSR1
SCHEMBL16951841 0.77 ALDH1A1 (0.48) MEN1KMT2ALMNAMAPTF2RL3
SCHEMBL12474328 0.77 BACE1 (0.35) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL16959422 0.77 FFAR4 (0.37) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL22181635 0.76 LMNA (0.35) MEN1KMT2ALMNAMAPTNPSR1
SCHEMBL22081760 0.75 CYP3A4 (0.48) MEN1KMT2ALMNAMAPTNPSR1
SCHEMBL15865213 0.75 SMN1; SMN2 (0.36) MEN1KMT2ALMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023118434-A1 PESTICIDALLY ACTIVE AMIDE COMPOUNDS GLOBACHEM NV (BE) 2023-06-29 WO disclosed
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE UBE CORPORATION (JP) 2023-06-22 US disclosed
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
EP-2621922-A1 A PROCESS FOR THE SYNTHESIS OF THIO-TRIAZOLO-GROUP CONTAINING COMPOUNDS BASF SE (DE) 2013-08-07 EP disclosed
WO-2012041858-A1 A PROCESS FOR THE SYNTHESIS OF THIO-TRIAZOLO-GROUP CONTAINING COMPOUNDS BASF SE (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192661-A1 1, 4, 5, 6-TETRAHYDROPYRIMIDINE-2-AMINE DERIVATIVE DHFR, DPYD, CYP2D6 MEN1 431/4885KMT2A 359/4885LMNA 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.